The statements regarding Herpafend have not been evaluated by the Food and Drug Administration (FDA). This product is not ...
The data represent the first clinical trial results of a 212Pb-based PSMA therapy. The findings support the further development of 212Pb-ADVC001 and may offer a new reference point in the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results